Aurinia Pharmaceuticals Intrinsic Value – Aurinia Pharmaceuticals looks to the past for insights to unlock future success, with share prices rising 0.74% in March 2023.
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a company that has recently seen a surge in investor interest as [...]
Aurinia Pharmaceuticals Stock Fair Value – Aurinia Pharmaceuticals Stock Soars 8% as Q4 Net Loss Narrows and Revenue Grows Year-Over-Year.
Trending News 🌧️ Aurinia Pharmaceuticals Stock Fair Value - The positive news sent investors into a buying spree, pushing Aurinia [...]
Aurinia Pharmaceuticals Experiences 2.00% Loss in 6 Months: What to Expect?
Trending News 🌧️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a biopharmaceutical company based in Canada. The company specializes in the research, [...]
Considering Investing in Aurinia Pharmaceuticals? Read This First!
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical stage biopharmaceutical company based in Victoria, British Columbia, Canada. The [...]
Dupont Capital Management Corp Increases Holdings in Aurinia Pharmaceuticals
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies to [...]
Aurinia Pharmaceuticals Shares Surge 7.9%
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH), a clinical stage biopharmaceutical company, witnessed a 7.9% rise in its shares recently. The [...]
Aurinia Pharmaceuticals Soars 36.1% to $5.62 Following Patent Settlement with Sun Pharmaceuticals
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH), a biopharmaceutical company based in Canada, recently announced the settlement of a patent dispute [...]
Analysts Give Aurinia Pharmaceuticals a ‘Moderate Buy’ Rating
Trending News 🌥️ Aurinia Pharmaceuticals Intrinsic Value – Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a publicly-traded biopharmaceutical company focused on developing [...]
Aurinia Pharmaceuticals’ Lupkynis Approved to Treat Lupus Nephritis in the UK
Trending News ☀️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical stage biopharmaceutical company focused on the development of aurinia saxatilis [...]
Aurinia Pharmaceuticals Stock Gaps Down Ahead of Trading
Trending News 🌥️ Aurinia Pharmaceuticals ($NASDAQ:AUPH) Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing treatments for [...]
